David S. Tomsche's most recent trade in Immucell Corp. was a trade of 10,000 Non Qualified Stock Options (Right to buy) done . Disclosure was reported to the exchange on Sept. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immucell Corp | David S. Tomsche | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2024 | 10,000 | 10,000 | - | - | Non Qualified Stock Options (Right to buy) | |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.55 per share. | 28 Aug 2024 | 2,186 | 131,797 (1%) | 0% | 3.5 | 7,760 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.55 per share. | 23 Aug 2024 | 6,005 | 129,611 (1%) | 0% | 3.6 | 21,318 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.55 per share. | 22 Aug 2024 | 10,000 | 123,606 (1%) | 0% | 3.6 | 35,500 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.72 per share. | 15 Aug 2024 | 4,811 | 110,434 (1%) | 0% | 3.7 | 17,883 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.67 per share. | 15 Aug 2024 | 3,172 | 113,606 (1%) | 0% | 3.7 | 11,641 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 3.57 per share. | 15 Aug 2024 | 2,017 | 105,623 (1%) | 0% | 3.6 | 7,195 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.37 per share. | 13 Mar 2023 | 900 | 98,226 (1%) | 0% | 5.4 | 4,833 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.47 per share. | 13 Mar 2023 | 831 | 99,737 (1%) | 0% | 5.5 | 4,546 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.20 per share. | 13 Mar 2023 | 400 | 96,826 (1%) | 0% | 5.2 | 2,080 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.50 per share. | 13 Mar 2023 | 309 | 98,906 (1%) | 0% | 5.5 | 1,700 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.24 per share. | 13 Mar 2023 | 300 | 97,126 (1%) | 0% | 5.2 | 1,572 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.25 per share. | 13 Mar 2023 | 200 | 97,326 (1%) | 0% | 5.3 | 1,050 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.24 per share. | 13 Mar 2023 | 100 | 98,426 (1%) | 0% | 5.2 | 524 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.24 per share. | 13 Mar 2023 | 100 | 98,526 (1%) | 0% | 5.2 | 524 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.53 per share. | 13 Mar 2023 | 100 | 100,337 (1%) | 0% | 5.5 | 553 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.44 per share. | 13 Mar 2023 | 100 | 100,506 (1%) | 0% | 5.4 | 544 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.53 per share. | 13 Mar 2023 | 100 | 99,837 (1%) | 0% | 5.5 | 553 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.34 per share. | 13 Mar 2023 | 80 | 98,306 (1%) | 0% | 5.3 | 427 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.51 per share. | 13 Mar 2023 | 71 | 98,597 (1%) | 0% | 5.5 | 391 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.54 per share. | 13 Mar 2023 | 69 | 99,906 (1%) | 0% | 5.5 | 382 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.54 per share. | 13 Mar 2023 | 69 | 100,006 (1%) | 0% | 5.5 | 382 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.54 per share. | 13 Mar 2023 | 69 | 100,106 (1%) | 0% | 5.5 | 382 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.54 per share. | 13 Mar 2023 | 69 | 100,237 (1%) | 0% | 5.5 | 382 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.54 per share. | 13 Mar 2023 | 69 | 100,406 (1%) | 0% | 5.5 | 382 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.52 per share. | 13 Mar 2023 | 31 | 99,937 (1%) | 0% | 5.5 | 171 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.52 per share. | 13 Mar 2023 | 31 | 100,037 (1%) | 0% | 5.5 | 171 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.52 per share. | 13 Mar 2023 | 31 | 100,137 (1%) | 0% | 5.5 | 171 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.52 per share. | 13 Mar 2023 | 31 | 100,168 (1%) | 0% | 5.5 | 171 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.20 per share. | 13 Mar 2023 | 10 | 98,326 (1%) | 0% | 5.2 | 52 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.29 per share. | 13 Mar 2023 | 7 | 98,316 (1%) | 0% | 5.3 | 37 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 5.33 per share. | 13 Mar 2023 | 3 | 98,309 (1%) | 0% | 5.3 | 16 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 10,000 | 10,000 | - | - | Non Qualified Stock Options (Right to buy) | |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.76 per share. | 08 Sep 2022 | 647 | 95,572 (1%) | 0% | 7.8 | 5,021 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.75 per share. | 08 Sep 2022 | 606 | 96,231 (1%) | 0% | 7.8 | 4,697 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.71 per share. | 08 Sep 2022 | 329 | 94,654 (1%) | 0% | 7.7 | 2,537 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.68 per share. | 08 Sep 2022 | 306 | 94,325 (1%) | 0% | 7.7 | 2,350 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.69 per share. | 08 Sep 2022 | 260 | 94,924 (1%) | 0% | 7.7 | 1,999 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.80 per share. | 08 Sep 2022 | 195 | 96,426 (1%) | 0% | 7.8 | 1,521 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.79 per share. | 08 Sep 2022 | 33 | 95,605 (1%) | 0% | 7.8 | 257 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.70 per share. | 08 Sep 2022 | 20 | 95,625 (1%) | 0% | 7.7 | 154 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.80 per share. | 08 Sep 2022 | 5 | 94,664 (1%) | 0% | 7.8 | 39 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.80 per share. | 08 Sep 2022 | 5 | 94,659 (1%) | 0% | 7.8 | 39 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.00 per share. | 08 Sep 2022 | 1 | 94,925 (1%) | 0% | 8 | 8 | Common Stock, $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.25 per share. | 01 Jun 2022 | 700 | 89,919 (1%) | 0% | 8.3 | 5,775 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.50 per share. | 01 Jun 2022 | 643 | 91,297 (1%) | 0% | 8.5 | 5,466 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.45 per share. | 01 Jun 2022 | 500 | 91,797 (1%) | 0% | 8.5 | 4,225 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.77 per share. | 01 Jun 2022 | 485 | 93,369 (1%) | 0% | 7.8 | 3,768 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.81 per share. | 01 Jun 2022 | 462 | 92,746 (1%) | 0% | 7.8 | 3,608 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.25 per share. | 01 Jun 2022 | 400 | 94,019 (1%) | 0% | 8.3 | 3,300 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.23 per share. | 01 Jun 2022 | 300 | 90,219 (1%) | 0% | 8.2 | 2,469 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.64 per share. | 01 Jun 2022 | 200 | 90,584 (1%) | 0% | 8.6 | 1,728 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.73 per share. | 01 Jun 2022 | 200 | 92,084 (1%) | 0% | 7.7 | 1,546 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.80 per share. | 01 Jun 2022 | 200 | 92,284 (1%) | 0% | 7.8 | 1,560 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.10 per share. | 01 Jun 2022 | 200 | 93,569 (1%) | 0% | 8.1 | 1,620 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.20 per share. | 01 Jun 2022 | 112 | 90,331 (1%) | 0% | 8.2 | 918 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.27 per share. | 01 Jun 2022 | 100 | 89,219 (1%) | 0% | 8.3 | 827 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.79 per share. | 01 Jun 2022 | 90 | 92,836 (1%) | 0% | 7.8 | 701 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.46 per share. | 01 Jun 2022 | 87 | 91,884 (1%) | 0% | 8.5 | 736 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.49 per share. | 01 Jun 2022 | 70 | 90,654 (1%) | 0% | 8.5 | 594 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.19 per share. | 01 Jun 2022 | 53 | 90,384 (1%) | 0% | 8.2 | 434 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.06 per share. | 01 Jun 2022 | 50 | 93,619 (1%) | 0% | 8.1 | 403 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 7.81 per share. | 01 Jun 2022 | 48 | 92,884 (1%) | 0% | 7.8 | 375 | Common stock $0.10 per value per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.37 per share. | 16 May 2022 | 3,400 | 89,119 (1%) | 0% | 8.4 | 28,458 | Common Stock, par valude $0.10 per share |
| Immucell Corp | David S. Tomsche | Director | Sale or transfer of securities back to the company at price $ 8.35 per share. | 16 May 2022 | 200 | 85,719 (1%) | 0% | 8.4 | 1,670 | Common Stock, par valude $0.10 per share |
| Immucell Corp | David S. Tomsche | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 10,000 | 10,000 | - | - | Incentive Stock Options (Right to buy) |